Study to Identify the Genetic Variations Associated With Phantom Limb Pain
NCT ID: NCT01462448
Last Updated: 2025-08-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
726 participants
OBSERVATIONAL
2012-03-31
2023-08-06
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Genetics and Phantom Limb Pain
NCT01517061
Exploring the Genetics of Neuropathic Pain
NCT03862365
Genetic and Blood Biomarkers in Neurological and Neuromuscular Diseases
NCT02780531
Observational Study of the Impact of Genetic Testing on Healthcare Decisions and Care in Interventional Pain Management
NCT02485795
Genetic Analysis of Hereditary Disorders of Hearing and Balance
NCT00023049
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
In order to understand the genetic aspects and ultimately develop more effective treatment options in the future, patients with and without PLP will be asked to give 30 mls of blood after overnight fasting. These blood samples will be de-identified and sent to the National Institutes of Health (NIH) in Bethesda, Maryland, where all of the genetic analyses will take place.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Phantom Limb Pain
Subjects will have lower or upper extremity amputation(s) that have resulted in the presence of phantom limb pain.
Blood Draw
Single blood draw of 30 ml
No Phantom Limb Pain
Subjects in the group will have a lower or upper extremity amputation(s) without the presence of phantom limb sensation.
Blood Draw
Single blood draw of 30 ml
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Blood Draw
Single blood draw of 30 ml
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* At least 18 years of age.
* Written informed consent and written authorization for use or release of health and research study information
* Single or multiple upper and/or lower limb amputation
* At least three months post-amputation
* Ability to follow study instructions and likely to complete required visit(s)
* Experienced PLP for at least one month and at least 3 times per week
* Phantom limb pain differentiated from residual limb pain by physical exam.
* Subjects taking blood thinners or other medications that do not increase risk during a blood draw.
Non-Chronic PLP Group:
* At least 18 years of age.
* Written informed consent and written authorization for use or release of health and research study information
* Single or multiple upper and/or lower limb(s) amputation
* At least three months post-amputation
* Ability to follow study instructions and likely to complete required visit(s)
* Experienced PLP less than 10 times total and/or for less than two weeks
* Subjects taking blood thinners or other medications that do not increase risk during a blood draw.
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Uniformed Services University of the Health Sciences
FED
Henry M. Jackson Foundation for the Advancement of Military Medicine
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Paul F. Pasquina, MD, MC
Role: PRINCIPAL_INVESTIGATOR
Walter Reed National Military Medical Center (WRNMMC)
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Walter Reed National Military Medical Center (WRNMMC)
Bethesda, Maryland, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Katz J, Melzack R. Pain 'memories' in phantom limbs: review and clinical observations. Pain. 1990 Dec;43(3):319-336. doi: 10.1016/0304-3959(90)90029-D.
Montoya P, Larbig W, Grulke N, Flor H, Taub E, Birbaumer N. The relationship of phantom limb pain to other phantom limb phenomena in upper extremity amputees. Pain. 1997 Aug;72(1-2):87-93. doi: 10.1016/s0304-3959(97)00004-3.
Kooijman CM, Dijkstra PU, Geertzen JHB, Elzinga A, van der Schans CP. Phantom pain and phantom sensations in upper limb amputees: an epidemiological study. Pain. 2000 Jul;87(1):33-41. doi: 10.1016/S0304-3959(00)00264-5.
Ramachandran VS, Hirstein W. The perception of phantom limbs. The D. O. Hebb lecture. Brain. 1998 Sep;121 ( Pt 9):1603-30. doi: 10.1093/brain/121.9.1603.
Sherman RA, Sherman CJ, Parker L. Chronic phantom and stump pain among American veterans: results of a survey. Pain. 1984 Jan;18(1):83-95. doi: 10.1016/0304-3959(84)90128-3.
Jensen TS, Krebs B, Nielsen J, Rasmussen P. Phantom limb, phantom pain and stump pain in amputees during the first 6 months following limb amputation. Pain. 1983 Nov;17(3):243-256. doi: 10.1016/0304-3959(83)90097-0.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HU0001-11-1-0005
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
20429
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.